- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04332146
Mindfulness-based Intervention for Postnatal Depression
The Impacts of Mindfulness-based Intervention on Symptoms and Cognition in Chinese Women With Postnatal Depressive Symptoms - A Randomized Controlled Clinical Trial
Postnatal psychopathology have adverse impact on both mothers and infants. Few postnatal women with depressive symptoms receive treatment, and pharmacological intervention has not been well accepted due to the medication side-effects. Recently, mindfulness-based interventions were found to be beneficial for symptoms in perinatal and antenatal women with depression. These non-pharmacological interventions require less resources and are more feasible for postnatal women to practice at home. To date, no randomized controlled trial has examined mindfulness-based intervention program as a treatment for women with postnatal depression. The proposed randomized controlled trial aims to examine the effects of an 8-week mindfulness-based intervention program on symptom and cognition for postnatal females with depressive symptoms.
A total of 70 postnatal women with depressive symptoms will be recruited from the psychiatric outpatient clinics in Hong Kong, and will be randomized into two groups: 1) an 8-week mindfulness-based intervention program (n=35); 2) a booklet-based psychoeducation control group (n=35). All participants will be assessed for depression, anxiety, stress, cognition, role functioning, quality of life, sleep quality and mindfulness ability at the baseline, 8 weeks, and 3 months after intervention. The intervention sessions will be held once weekly lasting 90 minutes for 8 weeks.
The investigators primarily hypothesize that participants in the mindfulness-based intervention group will improve depressive symptom after 8 weeks compared with the control group. Secondary, the mindfulness-based intervention will improve anxiety, stress, cognitive functions, sleep quality, quality of life and mindfulness ability.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jingxia Lin, PhD
- Phone Number: 852-39176311
- Email: jxlin@hku.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Queen Mary Hospital
-
Contact:
- Jingxia Lin, PhD
- Phone Number: 852-39176311
- Email: jxlin@hku.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Females aged from 18 and above
- The Edinburgh Postnatal Depression Scale cut-off score of >=9
- At least 6 weeks, and up to one and half years after childbirth
- Cantonese-speaking Chinese
Exclusion Criteria:
- Severe physical illness (myocardial infarction, hypertension, fracture, spinal problems in which yoga may be contraindicated), and seizure disorders.
- Comorbid substance dependence
- Women with psychotic depression, severe eating disorders, actively suicidal or obsessive-compulsive disorders
- Known pregnancy
- A history of bipolar disorder, schizophrenia, brain trauma or organic brain disease, mental retardation, or antisocial personality disorder
- Practice of mindfulness (in forms of Tai Chi, Qi gong or yoga etc.) more than twice a week during the previous three months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mindfulness-based intervention
|
The MBI-p-R was developed in line with the model of Mindfulness-based Stress Reducation (MBSR) proposed by Kabat-Zinn.
It will be conducted for 1.5 hours for each session, once a week for 8 weeks.
There are four key operational components to be included in each session: engagement and introduction, mindfulness practices, daily life application, and consolidation of learning.
|
Active Comparator: Booklet-based psychoeducation group
|
The participants in the control group will be provided a booklet at baseline, including general information in handling every day stress by a new mother, as well as a record for their weekly activities.
The contents covered a range of topics including work-stress, balanced diet, physical exercise, sleeping quality, bonding with baby and the treatment for depression.
The participants will be contacted by phone call and/or whatsapp weekly for a short talk based on the record and content on the booklet.
They will also be asked to record their daily life weekly for discussion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Depression at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Depression at 3 months
Time Frame: Change from 8 weeks to 3 months
|
The Edinburgh Postnatal Depression Scale, total score 0-30, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline Anxiety at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Anxiety at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Depression Anxiety Stress Scale, Anxiety subscore 0-42, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Stress at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Stress at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Depression Anxiety Stress Scale, Stress subscore 0-42, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Executive Function at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Trial Making Test, reaction time is recorded, shorter time means better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Executive Function at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Trial Making Test, reaction time is recorded, shorter time means better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Attention at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Attention at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Letter Cancellation Test, correct rate and time are recorded, higher correct rate and shorter time mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Working Memory at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Working Memory at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Digit-Span Test, minimum 0, maximum 14, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Visual-Motor Coordination at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Visual-Motor Coordination at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Digit-Symbol-Coding Test, minimum 0, maximum 133, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Role Functioning at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Role Functioning at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Role Functioning Scale, minimum 4, maximum 38, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Quality of Life at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Quality of Life at 3 months
Time Frame: Change from 8 weeks to 3 months
|
The Short Form Health Survey, minimum score 0, and maximum score 100, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Sleep Quality at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Sleep Quality at 3 months
Time Frame: Change from 8 weeks to 3 months
|
Pittsburg Sleep Quality Index, minimum 0, maximum 21, higher scores mean worse outcome.
|
Change from 8 weeks to 3 months
|
Change from Baseline Mindfulness Levels at 8 weeks
Time Frame: Change from baseline to 8 weeks
|
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
|
Change from baseline to 8 weeks
|
Change from 8 weeks Mindfulness Levels at 3 months
Time Frame: Change from 8 weeks to 3 months
|
The Five Facet Mindfulness Questionnaire-Revised, minimum 39, maximum 195, higher scores mean better outcome.
|
Change from 8 weeks to 3 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total attendant classes during the 8-week interventions
Time Frame: At 8 weeks
|
The number of classes the participants attended during the 8-week period will be recorded
|
At 8 weeks
|
Self-practice time
Time Frame: At 8 weeks
|
How much time the participants spend for self-practice at home will be recorded
|
At 8 weeks
|
Self-practice time
Time Frame: At 3 months
|
How much time the participants spend for self-practice at home will be recorded
|
At 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jingxia Lin, PhD, The University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UW17-431
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postnatal Depression
-
Lancashire Care NHS Foundation TrustUniversity of ManchesterCompletedDepression, Postpartum | Postnatal Depression in British South Asian WomenUnited Kingdom
-
University of CopenhagenUniversity of AarhusActive, not recruitingInfant Social Withdrawal | Maternal Postnatal DepressionDenmark
-
Nottingham Trent UniversitySheffield Hallam University; University of Manchester; Teesside UniversityRecruitingPostnatal DepressionUnited Kingdom
-
Ministry of Health, MalaysiaCompleted
-
University of MelbourneCompleted
-
Ana Ganho ÁvilaCentro Hospitalar e Universitário de Coimbra, E.P.E.Not yet recruiting
-
The Hong Kong Polytechnic UniversityCompletedPostnatal DepressionHong Kong
-
Peshawar Medical CollegePakistan Association of Cognitive TherapistsCompletedPostnatal DepressionPakistan
-
University College, LondonCompleted
-
National Society for the Prevention of Cruelty...UnknownPostnatal DepressionUnited Kingdom
Clinical Trials on Mindfulness-based program (MBI-p-R)
-
City, University of LondonCompletedParkinson's DiseaseUnited Kingdom
-
Sunnybrook Health Sciences CentreCompletedDepression | Anxiety | Mood
-
Vanderbilt University Medical CenterTerminatedDepression | Stress | Major Depressive DisorderUnited States
-
Vanderbilt University Medical CenterCompletedChronic Pain | Pain, Chronic | Pain, Intractable | Pain Syndrome | Pain, NeuropathicUnited States
-
Göteborg UniversitySahlgrenska University Hospital, SwedenCompleted
-
Karl Landsteiner Institute for Lung Research and...Klinik Ottakring; University of Vienna; Klinik Floridsdorf; Therme Wien Med (Ambulant...CompletedChronic Obstructive Pulmonary Disease ExacerbationAustria
-
University of Massachusetts, WorcesterNational Center for Complementary and Integrative Health (NCCIH)CompletedAnxiety Disorder in Conditions Classified ElsewhereUnited States
-
University of MiamiCompleted
-
Vanderbilt University Medical CenterNational Center for Complementary and Integrative Health (NCCIH)RecruitingChronic Low-back Pain | Postsurgical Pain | Lumbar Spine SurgeryUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)Recruiting